Like MDM2, MDMX is genetically amplified in several types of cancers, and therefore, the inactivation of both MDM2 and MDMX is believed to be crucial to induce an effective p53 response in tumor cells that express wild-type p53. The gene discussed is MDM2; the disease is neoplasm.